re:" My real concern is if there is a bigger game in play: to ruin the company because it's a threat to AXON or other BP. Does anyone else share this concern?"
Yes. Well, yes and no. Bigger game, possibly, yes.
There was a post on YMB that suggested AXON was "run by hedge funds". Now I don't know everything about AXON, but let's say certain stock pundits and associates steered a lot of big money into bio-techs that they recommended (AXON perhaps?). Now maybe some of the investors are starting to realize that they backed the wrong horse. Or, they don't want the other big investors to find out. If one of them left, it would crash the stock for the others, who would then be stuck. Musical chairs, well, whatever, people with a lot of money to lose because of bad advice could end up pretty ticked off. Could be bad for whoever got them into it, depending what sort of people are involved. 'Desperate times call for desperate measures?
So, what would trigger a collapse of the house of cards and how to prevent it? Only if there was something better out there. Which, as we know, there is. And there seems to be people out there for whom manipulation isn't just a last resort, probably a first resort and presumed answer to everything.
Obviously, there is an effort underway by market manipulators to keep new investors away from avxl. But what if the main thing is to prevent large funds from buying, for as long as possible, and/or also from deserting their present cash cow companies that have the market cornered with crappy drugs that don't work, but maybe not for long. They want to make that "long" as long as possible. It's possible that time is being bought for certain high rollers to reposition themselves. Or, so we may theorize. Assuming they're smart. Otherwise, bad for them. Eventually.
This sort of attack is usually waged on weaker companies, to destroy their ability to obtain equity financing, which tends to be ruinous. That is not the case here. AVXL has sufficient cash to fund the next stage major trial on their own, if they need to. Commercialization is going to happen. So the main effect is that of delaying future investor awareness or creating obstacles for legit fund managers who have guidelines like, share price greater than $5. Plus, if you're a FM slated with narrowing down a list of hundreds of bio-techs, who's going to take the time to see what all these "investor alert" law firm "investigations" are really about. It's likely going to get passed over initially. So, that's the extent of the damage being done, imo.
Unfortunately, very annoying, to say the least, for (us) retail holders.
